Literature DB >> 8827022

Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

M F Dixon1, R M Genta, J H Yardley, P Correa.   

Abstract

The Sydney System for the classification of gastritis emphasized the importance of combining topographical, morphological, and etiological information into a schema that would help to generate reproducible and clinically useful diagnoses. To reappraise the Sydney System 4 years after its introduction, a group of gastrointestinal pathologists from various parts of the world met in Houston, Texas, in September 1994. The aims of the workshop were (a) to establish an agreed terminology of gastritis; (b) to identify, define, and attempt to resolve some of the problems associated with the Sydney System. This article introduces the Sydney System as it was revised at the Houston Gastritis Workshop and represents the consensus of the participants. Overall, the principles and grading of the Sydney System were only slightly modified, the grading being aided by the provision of a visual analogue scale. The terminology of the final classification has been improved to emphasize the distinction between the atrophic and nonatrophic stomach; the names used for each entity were selected because they are generally acceptable to both pathologists and gastroenterologists. In addition to the main categories and atrophic and nonatrophic gastritis, the special or distinctive forms are described and their respective diagnostic criteria are provided. The article includes practical guidelines for optimal biopsy sampling of the stomach, for the use of the visual analogue scales for grading the histopathologic features, and for the formulation of a comprehensive standardized diagnosis. A glossary of gastritis-related terms as used in this article is provided.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8827022     DOI: 10.1097/00000478-199610000-00001

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  1415 in total

Review 1.  ACP. Best practice no 154. February 1999. Helicobacter pylori.

Authors:  C A McNulty; J I Wyatt
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

2.  Reproducibility and intragastric variation of duodenogastric reflux using ambulatory gastric bilirubin monitoring.

Authors:  D K Manifold; A Anggiansah; R E Marshall; W J Owen
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

3.  Analysis of Helicobacter pylori vacA gene and serum antibodies to VacA in Japan.

Authors:  D Shirasaka; N Aoyama; K Satonaka; K Shirakawa; H Yoshida; T Sakai; T Ikemura; Y Shinoda; M Sakashita; M Miyamoto; K Yahiro; A Wada; H Kurazono; T Hirayama; M Kasuga
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

4.  Modulation of Helicobacter pylori induced interleukin-8 synthesis in gastric epithelial cells mediated by cag PAI encoded VirD4 homologue.

Authors:  J E Crabtree; D Kersulyte; S D Li; I J Lindley; D E Berg
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

5.  The significance of cagA and vacA subtypes of Helicobacter pylori in the pathogenesis of inflammation and peptic ulceration.

Authors:  M C Gunn; J C Stephens; J A Stewart; B J Rathbone; K P West
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

6.  Helicobacter pylori infection.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

7.  The phenotype of gastric mucosa coexisting with Barrett's oesophagus.

Authors:  M Rugge; V Russo; G Busatto; R M Genta; F Di Mario; F Farinati; D Y Graham
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

8.  Pathology and cost effectiveness of endoscopy surveillance for premalignant gastric lesions.

Authors:  M Rugge; M Cassaro; G Pennelli; V M Russo; F Di Mario; F Farinati
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

9.  Evaluation of gastric cancer risk using topography of histological gastritis: a large-scaled cross-sectional study.

Authors:  Shinobu Imagawa; Masaharu Yoshihara; Masanori Ito; Shigeto Yoshida; Yoshihiro Wada; Masana Tatsugami; Akemi Takamura; Shinji Tanaka; Ken Haruma; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2007-11-13       Impact factor: 3.199

10.  Serum glycan signatures of gastric cancer.

Authors:  Sureyya Ozcan; Donald A Barkauskas; L Renee Ruhaak; Javier Torres; Cara L Cooke; Hyun Joo An; Serenus Hua; Cynthia C Williams; Lauren M Dimapasoc; Jae Han Kim; Margarita Camorlinga-Ponce; David Rocke; Carlito B Lebrilla; Jay V Solnick
Journal:  Cancer Prev Res (Phila)       Date:  2013-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.